FDA OKs Pfizer Drug for Rare, Fast-Killing Type of Leukemia

TRENTON, N.J. (AP) The Food and Drug Administration has approved a new medicine for use against a rare, rapidly progressing blood cancer after other treatments have failed.The agency approved Pfizer Inc.’s Besponsa for patients with a type of advanced acute lymphoblastic leukemia. By then, life expectancy is low.”These patients have few treatments available and today’s

[ Read More ]